BioVersys AG (SWX:BIOV)
Switzerland · Delayed Price · Currency is CHF 28.50
-0.10 (-0.35%)
At close: Apr 1, 2026
BioVersys AG Market Cap
BioVersys AG has a market cap or net worth of 166.67 million as of April 2, 2026. Its market cap has decreased by -19.17% in one year.
Market Cap
166.67M
Enterprise Value
105.89M
Revenue
3.18M
Ranking
n/a
PE Ratio
n/a
Stock Price
28.50
Market Cap Chart
Since February 6, 2025, BioVersys AG's market cap has decreased from 207.92M to 166.67M, a decrease of -19.84%. That is a compound annual growth rate of -17.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 166.67M | 16.80% |
| Dec 30, 2025 | 142.69M | -31.37% |
| Feb 6, 2025 | 207.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Idorsia | 872.73M |
| Basilea Pharmaceutica AG | 668.66M |
| Newron Pharmaceuticals | 315.24M |
| Santhera Pharmaceuticals Holding AG | 216.70M |
| Molecular Partners AG | 116.72M |
| Xlife Sciences AG | 114.77M |
| EvoNext Holdings | 6.56M |
| Addex Therapeutics | 4.50M |